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Safe dose of levobupivacaine (Chirocaine â ) in caudal analgesia in children EditorÐCaudal analgesia is commonly used for postoperative pain relief in children of all ages having surgery below the diaphragm, as con®rmed in Sanders' recent survey of UK practice of paediatric regional anaesthesia. 1 Bupivacaine is named as the most common local anaesthetic drug of choice, and it would have been interesting to know what dose of local anaesthetic was used. The isomer levobupivacaine (Chirocaine â ) is now regularly used in the Manchester Children's Hospitals, for theoretical reasons of improved safety. 2 I have conducted an audit, looking retrospectively at the doses of levobupivacaine used in the caudal space over the last six months by anaesthetists at Booth Hall Children's Hospital in Manchester.
I studied the operating theatres' recovery book, and extracted the case numbers of all patients recorded as having caudal analgesia during the period March to September, 2002. I then looked at the patient records and noted the dose of local anaesthetic used and the weight of the patient. I calculated the dose of levobupivacaine received in mg kg ±1 and plotted this on a scatter chart (Fig. 1 ).
There were 79 caudals recorded as having been performed, but only 44 (56%) case records were present in the medical records department at Booth Hall. Twenty records were absent with unknown whereabouts, eight records were held at another hospital site, and seven were tagged as absent (e.g. for clinic appointment). Surgical operations ranged from inguinal herniotomies [32/79 (41%)], to circumcision, orchidopexy, hydrocoele repair, and exploration of testicular torsion. The weights of the children ranged from 2.8 to 59 kg, and ages ranged from 8 days to 14 yr with 64/79 (81%) being <6 yr old. An aseptic technique was recorded as being used by the anaesthetist in 34/44 (77%) of the records. A 22-gauge Jelco â cannula was used in 28/44 (64%) of cases, a 20G in six cases, 18G in two, 24G in one, 21G needle in one, and no reference was made in ®ve cases. The local anaesthetic used was plain 2.5 mg ml ±1 levobupivacaine (Chirocaine â ) in all but two cases, who received bupivacaine 0.25% with epinephrine (1 in 200 000) at a dose of 2.5 mg kg ±1 . The dose of levobupivacaine was in excess of the possible limit of 2 mg kg ±1 for bupivacaine in 16/44 (36%) of patients. The majority of these patients were <20 kg. Three patients weighing >30 kg received relatively low doses of local anaesthetic, but they also had clonidine (range 1±1.5 mg kg ±1 ) added to the caudal space. No other adjuvants were used.
Although levobupivacaine 1.25 mg kg ±1 each side is recommended for ilio-inguinal nerve block, 3 there is no evidence to support the recommended maximum dose of levobupivacaine for caudal analgesia in children. Is it assumed to be the same as the limit recommended for bupivacaine at 2 mg kg ±1 (although this drug is not yet licensed for use in children)? In this audit, more than one-third of patients received a dose in excess of this, but came to no harm. Further formal studies are needed, but I have shown that administering a dose of levobupivacaine 2.5 mg kg ±1 into the caudal space in children is a common practice at our hospital and has produced no clinical problems.
R. H. Smith Manchester, UK
EditorÐThank you for the opportunity to reply to Dr Smith's letter on the dosing of levobupivacaine in paediatric caudal analgesia. Although much potentially valuable data was not analysed from the 35/79 (44%) medical records, which could not be located, some interesting points arose.
In 42/44 (95%) of caudals in Smith's report, levobupivacaine was the local anaesthetic of choice. In my survey, levobupivacaine was used by only 7/210 (3%) of respondents. 1 It is exciting to see development and change for the patients' bene®t in our practice, brought about by new evidence on the possible reduced toxicity of levobupivacaine compared with bupivacaine. This is the sort of fact-based, highly transferable knowledge alluded to in my paper that can spread rapidly in the medical community. In Smith's report, only 3/44 (7%) of local anaesthetic doses had an adjuvant added. Lack of opiate adjuvants could be because the cases reported were suitable for day surgery. Of more interest, is the lack of use of epinephrine. Although the interpretation of test doses can be dif®cult in the anaesthetized child, many authorities recommend the use of epinephrine in test doses and monitoring for heart rate changes as well as changes in ECG morphology. 4 5 It would be useful to know how test doses were interpreted.
My survey did not attempt to record the doses of local anaesthetic used in caudal analgesia. Doses are dependent not just on weight, but also on operative site and the age of the patient. Toxicity of local anaesthetics is potentially increased in infants, and especially neonates, because of decreased plasma protein binding of the drug and increased elimination half-time. Consequently, recommended bupivacaine doses are reduced by Correspondence half in the neonate. 6 An analysis of dosing by age in the report would have been of interest. If reduced toxicity is a prime concern, ropivacaine has been shown to be less toxic than levobupivacaine and bupivacaine in isolated heart preparations, 7 and whole animal preparations. 8 Ropivacaine has been available for longer than levobupivacaine and there are a substantial number of clinical studies supporting its use. For all of these drugs, maximum allowable doses must be considered carefully, as toxicity depends not only on dose of the drug and the weight of the patient, but also on age, physiological status, speed of injection, and site of injection. Although no adverse events were reported in the records reviewed, care must be taken in generalizing on the safety of the doses reported, especially in the very young, the acidotic patient, or those with decreased levels of a-1 acid glycoprotein and albumin.
J. C. Sanders
Albuquerque, USA Anaesthesia for Caesarean section in women with heart disease EditorÐIn the case reported by Olufolabi and colleagues 1 of Caesarean section in a woman with complex arrhythmias and an implantable cardioverter de®brillator, I was surprised that anaesthesia comprised of a conventional thiopental/succinylcholine induction and nitrous oxide/iso¯urane maintenance. The authors acknowledged that regional anaesthesia avoids the arrhythmogenic and cardiac depressant effects of volatile agents, but omitted to mention that an opioid-based general anaesthetic regimen with remifentanil, 2 3 can reduce or eliminate the need for vapour without risking the sympathetic blockade associated with a regional block. The fetal effects of anaesthetic and analgesic agents are`innocuous and reversible'. 4 There is no need to restrict doses for women with cardiac or cerebrovascular disease requiring Caesarean section on account of fetal concerns. Fetal well-being depends on maintenance of haemodynamic stability and avoidance of aortocaval compression, hypoxaemia and hypercarbia. As all babies born to high-risk mothers will be delivered into the hands of a neonatal paediatrician for ventilatory support, any opioid-induced respiratory depression should be of little or no consequence.
Two ®nal points: it was suggested that epidural anaesthesia might be preferable to a spinal block because a more controlled onset of effect is possible. Incremental spinal anaesthesia via an intrathecal catheter might confer a better quality of anaesthesia with a similar degree of haemodynamic control but no risk of local anaesthetic toxicity. 5 Lastly, the authors stated that`routine antire¯ux prophylaxis' was administered. Antacid therapy is routine in UK obstetric practice, but anti-re¯ux therapy is not. What did the patient receive?
D. M. Levy Nottingham, UK
EditorÐWe thank Dr Levy for his response and are grateful for the opportunity to reply. Opioid-based anaesthesia is a valid alternative and indeed, the effects of opioid-type drugs on the fetus are well known and reversible. It is, however, not practical to entirely`eliminate the need for vapour' because of the risk of awareness, as one of his referenced articles, in which nitrous oxide and iso¯urane were used, con®rmed.
3 Furthermore, the induction of anaesthesia to delivery time period for Caesarean section can be signi®cantly shortened in experienced surgical hands, after which opioids can be promptly introduced, and the concentration of the volatile agent reduced. The short interval reduces the likelihood of high blood concentrations of iso¯urane, should one be particularly concerned.
Remifentanil has been extensively used by the ®rst author (AJO).
6±8 Despite its unique pharmacokinetic pro®le, it may not be the ideal opioid for Caesarean section, because of the problem of inadequate pain control in the postoperative period.
9 10 At the time of this case, it was not available to us in our institution. We agree with Dr Levy that continuous spinal anaesthesia is an option. We refer him to the case report referenced in our article.
11
Finally, the patient received ranitidine 150 mg the night before and early on the morning of surgery, with 30 ml sodium citrate before induction. Clearly, this is antacid medication although one is aiming to prevent re¯ux of hazardous stomach contents.
